Phase I study of iodine I 131 monoclonal antibody Lym-1 [monoclonal antibody LYM 1 I-131] in patients with previously treated diffuse large cell lymphoma [diffuse large B-cell lymphoma].
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2014
At a glance
- Drugs Monoclonal antibody LYM 1 I-131 (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 08 Jan 2014 Status changed from active no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Oct 2005 New trial record.